Raymond James & Associates’s Invesco S&P 500 Equal Weight Health Care ETF RSPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.44M Sell
44,797
-1,168
-3% -$36.6K ﹤0.01% 2448
2024
Q2
$1.38M Sell
45,965
-509
-1% -$15.4K ﹤0.01% 2393
2024
Q1
$1.48M Sell
46,474
-603
-1% -$18.5K ﹤0.01% 2352
2023
Q4
$1.4M Buy
47,077
+215
+0.5% +$5.89K ﹤0.01% 2309
2023
Q3
$1.28M Sell
46,862
-28
-0.1% -$815 ﹤0.01% 2294
2023
Q2
$1.4M Sell
46,890
-970
-2% -$28.4K ﹤0.01% 2286
2023
Q1
$1.4M Sell
47,860
-340
-0.7% -$9.89K ﹤0.01% 2249
2022
Q4
$1.39M Sell
48,200
-12,940
-21% -$360K ﹤0.01% 2231
2022
Q3
$1.54M Buy
61,140
+8,270
+16% +$227K ﹤0.01% 2132
2022
Q2
$1.42M Sell
52,870
-9,890
-16% -$280K ﹤0.01% 2218
2022
Q1
$1.92M Sell
62,760
-31,780
-34% -$951K ﹤0.01% 2158
2021
Q4
$3.03M Buy
94,540
+10,940
+13% +$333K ﹤0.01% 1876
2021
Q3
$2.49M Buy
83,600
+41,480
+98% +$1.28M ﹤0.01% 1944
2021
Q2
$1.23M Buy
42,120
+1,420
+3% +$40.2K ﹤0.01% 2445
2021
Q1
$1.09M Sell
40,700
-26,420
-39% -$703K ﹤0.01% 2449
2020
Q4
$1.76M Sell
67,120
-119,310
-64% -$2.97M ﹤0.01% 1970
2020
Q3
$4.39M Buy
186,430
+4,650
+3% +$109K 0.01% 1297
2020
Q2
$4.04M Sell
181,780
-10,520
-5% -$225K 0.01% 1322
2020
Q1
$3.64M Sell
192,300
-17,370
-8% -$368K 0.01% 1215
2019
Q4
$4.64M Buy
209,670
+14,940
+8% +$312K 0.01% 1303
2019
Q3
$3.82M Sell
194,730
-54,140
-22% -$1.08M 0.01% 1381
2019
Q2
$5.04M Sell
248,870
-73,530
-23% -$1.43M 0.01% 1207
2019
Q1
$6.36M Sell
322,400
-39,580
-11% -$763K 0.01% 1057
2018
Q4
$6.43M Sell
361,980
-5,750
-2% -$109K 0.01% 978
2018
Q3
$7.58M Buy
367,730
+42,100
+13% +$824K 0.01% 991
2018
Q2
$5.95M Sell
325,630
-103,730
-24% -$1.88M 0.01% 1089
2018
Q1
$7.71M Buy
429,360
+11,090
+3% +$206K 0.01% 914
2017
Q4
$7.51M Sell
418,270
-96,160
-19% -$1.7M 0.01% 912
2017
Q3
$9.02M Buy
514,430
+11,730
+2% +$204K 0.02% 792
2017
Q2
$8.75M Sell
502,700
-179,450
-26% -$2.98M 0.02% 768
2017
Q1
$10.9M Buy
682,150
+101,350
+17% +$1.58M 0.03% 622
2016
Q4
$8.47M Buy
580,800
+116,300
+25% +$1.72M 0.02% 709
2016
Q3
$7.23M Buy
464,500
+368,650
+385% +$5.79M 0.02% 756
2016
Q2
$1.45M Sell
95,850
-20,470
-18% -$305K ﹤0.01% 1519
2016
Q1
$1.68M Sell
116,320
-16,010
-12% -$227K 0.01% 1378
2015
Q4
$2.03M Buy
+132,330
New +$1.97M 0.01% 1253
2015
Q3
Sell
-101,390
Closed -$1.62M 2365
2015
Q2
$1.62M Sell
101,390
-298,320
-75% -$4.72M 0.01% 1447
2015
Q1
$6.2M Buy
+399,710
New +$5.98M 0.03% 640
2013
Q4
Sell
-194,510
Closed -$1.95M 2017
2013
Q3
$1.95M Buy
194,510
+2,890
+2% +$28.6K 0.02% 892
2013
Q2
$1.8M Buy
+191,620
New +$1.78M 0.02% 861

Other funds holding RSPH

Raymond James & Associates's RSPH Position: Q3 2024 in Review

Raymond James & Associates reduced its Invesco S&P 500 Equal Weight Health Care ETF (RSPH) stake by 2.5% in Q3 2024, selling an estimated $36.6K and leaving 44,797 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2448.

Raymond James & Associates first reported a position in RSPH in Q2 2013 and has held it in 40 quarters since. The position peaked at $10.9M in Q1 2017. 186 funds tracked by Wall St. Rank hold RSPH as of Q3 2024.

  • Raymond James & Associates held 44,797 shares of Invesco S&P 500 Equal Weight Health Care ETF worth $1.44M as of Q3 2024.
  • Raymond James & Associates sold 1,168 Invesco S&P 500 Equal Weight Health Care ETF shares in Q3 2024, an estimated $36.6K.
  • Invesco S&P 500 Equal Weight Health Care ETF made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2448 holding.
  • Raymond James & Associates first reported a position in Invesco S&P 500 Equal Weight Health Care ETF in Q2 2013 and has held it in 40 quarters since.
  • Raymond James & Associates's Invesco S&P 500 Equal Weight Health Care ETF position peaked at $10.9M in Q1 2017.
  • 186 funds tracked by Wall St. Rank held Invesco S&P 500 Equal Weight Health Care ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.